Clinical trial NCT03470844: Perioperative Research Into Memory: Cognitive Outcome Following Major Burns
Official title: Using Cognitive Tests and Functional MRI to Investigate Long Term Cognitive Dysfunction Following a Critical Illness Due to a Major Burn Injury
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Major Injury
Keywords: Major burns
Intensive Care Medicine
Neurocognitive dysfunction
Functional magnetic resonance imaging
Neuroinflammation
Long term quality of life
Lead sponsor: Chelsea and Westminster NHS Foundation Trust
Sponsor class: OTHER
Collaborators: name: Imperial College Healthcare NHS Trust
name: University of Westminster
First posted: 2018-03-20
Enrollment: 32
Sex: ALL
Minimum age (years): 16
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients with severe burn injury admitted to a Burn Intensive Care Unit

Brief summary: The long term survival of patients who require admission to critical care (CC) following a major burn injury (MBI) continues to improve with advanced clinical management. There has been increasing interest into cognitive dysfunction (CD) due to neuroinflammation (NI) following CC, anaesthesia, surgery, and the association of NI with diseases characterised by CD such as Alzheimer's disease. Patients who suffer a MBI and who subsequently require admission to CC will be at uniquely high risk for CD. MBI produces an exaggerated and prolonged systemic inflammatory response, with NI demonstrated in animal models. Additionally NI can be exaggerated by insults such as sepsis, anaesthesia, and surgical trauma, common and often necessary following MBI. The aim of this study is to identify CD using cognitive tests to examine for deficits in working memory and executive function. Test proposed to use are the Hopkins Verbal Learning and Verbal Fluency tests, and a validated computerised battery (CogState). Neuroinflammation and underlying pathophysiology using fMRI and spectroscopy, known to demonstrate biomarkers for CD and NI. QoL will be assessed using the validated EQ-5D tool.

The Inclusion criteria; patients who survive their burns injury (greater than 15% total body surface area) and require mechanical ventilation. Primary exclusion criteria; admission with toxic epidermal necrolysis syndrome, and evidence of head trauma.

Detailed description: This is a novel, proof of principle, prospective, cohort design, observational clinical study to assess for functional brain reorganisation, structural changes and long-term cognitive dysfunction following major burns injury and intensive care admission. The hypothesis is that following a major burns injury and intensive care admission patients will have neurocognitive dysfunction and demonstrable functional alterations seen on functional MRI due to neuroinflammation as a result of the primary injury and subsequent inflammatory insults.

Eligibility criteria: Inclusion Criteria:

* Survival following admission to Chelsea and Westminster Burns Intensive Care Unit between 2004-2013 with a burn injury \> 15% total body surface area, requiring intubation and ventilation

Exclusion Criteria:

* Patients under 16.
* Patients with toxic epidermal necrolysis syndrome or evidence of head trauma.
* Patients with evidence of risk to psychological safety from inclusion in study: any patient currently held under section of the Mental Health Act, any patient receiving formal psychiatric treatment (including involvement in a Personality Disorder Unit, being under voluntary section, current re-occurrence of chronic self harm), any patient currently detained at her Majesty's pleasure, any current substance abuse, or at the discretion of professional opinion following historical assessment of notes. - Patients with contraindications to MRI (patients with non-compatible pacemakers, patients with metallic foreign bodies e.g. metal sliver in their eye, patients with non-compatible surgical metal work, patients with severe claustrophobia).
* Patient refusal or inability to give full informed consent.
* Patients unable to understand plain verbal or written English.

Primary outcomes:
measure: Neurocognitive function
timeFrame: 5 years
Secondary outcomes:
measure: Neuroinflammatory changes analysis.
timeFrame: 5 years
Other outcomes:
measure: Long-term quality of Life
timeFrame: 5 years
Locations:
city: London
country: United Kingdom
facility: The Burn Intensive Care Unit (BICU), Chelsea and Westminster Hospital
Study officials:
affiliation: Chelsea and Westminster Hospital
name: Marcela Vizcaychipi, MD PhD FRCA
role: STUDY_CHAIR
References: